Prostate Cancer Daily

July 22, 2026

Videos

Peer-to-Peer Clinical Conversations

Radiopharmaceuticals in Prostate Cancer Part 4A: Endpoints, Immunotherapy, and Future Directions - Michael Morris & Rana McKay

Michael J. Morris

Michael Morris and Rana McKay discuss regulatory endpoints and emerging immunotherapy strategies in advanced prostate cancer with Philip Kantoff.

Integrating Genomic Prognostic and Hallmark Signatures to Predict Outcomes in Active Surveillance - Kevin Shee

Kevin Shee

Kevin Shee analyzes Decipher® GRID whole-transcriptome data in 500 active surveillance patients from UCSF.

Beyond the Abstracts

Phase II Trial of Combination Radiation, Hormone, and Immunotherapy in Grade Group 5 Prostate Cancer - Beyond the Abstract

Lesion Absorbed Dose-Response Relationship in Patients with Metastatic Castration-Resistant Prostate Cancer Undergoing [177Lu]Lu-PSMA-617 Radiopharmaceutical Therapy - Beyond the Abstract

Conference Coverage

ASCO 2026: Impact of Baseline Demographics on Therapy Management in Patients with mCRPC Treated with Talazoparib + Enzalutamide in the TALAPRO-2 Study: Extended Follow-Up

ASCO 2026: Safety and Preliminary Efficacy of M9466 (HRS-1167) in Combination with AAP in Patients with Metastatic Prostate Cancer in the Phase 1 DDRiver 501 Study

AUA 2026: Real-world Characteristics, Treatment Utilization, and Outcomes Among Patients with Metastatic Hormone-sensitive Prostate Cancer (mHSPC) Treated in Community Urology Centers in the US: A PRECISION Data Platform Study

APCCC 2026: Prevention and Management of Radioligand Therapy Induced Xerostomia

PSMA and Beyond 2026: Review of Phase 1/2 Compounds Recently Published

Articles

Editor Selected Abstracts and Commentaries

Prostate Cancer

Racial Differences in Secondary Treatment Pathways and Survival in Localized Prostate Cancer.

Interference of Clonal Hematopoiesis in cfDNA Liquid Biopsy Testing & Identification of Actionable Alterations in Large Diverse Cohort of US Veterans.

Prostate cancer survivorship in modern times - insights into management of erectile dysfunction and urinary incontinence for clinically localized prostate cancer survivors in the United States.

Patient-reported Outcomes After Prostate Stereotactic Body Radiotherapy at 5 yr: Results from the PACE-B Trial.

Optimizing prostate biopsy decision making - (MUSIC-screen): A 1:1 randomized controlled trial comparing micro-ultrasound versus multiparametric magnetic resonance imaging for prostate cancer diagnosis.

Evaluation of an Artificial Intelligence Communication Platform for Racial Biases in Pretest Education About Prostate Cancer Germline Testing.

Raman spectroscopic signatures of prostate cancer progression: correlation with gleason score.

Imaging Features That Predict Indeterminate Bone Lesion Outcomes on 18F-DCFPyL PSMA PET/CT Scan: A Multicenter Cohort of 42 Biopsy-Proven Lesions - Beyond the Abstract

CONNECT WITH US

Questions or Comments? Email us at editors@urotoday.com

Digital Science Press, LLC
2011 Phaethon Lane,
Reno, NV 89523

You are receiving this email because you have chosen to receive emails from UroToday.

Add us to your address book View this email as a web page Forward to a colleague Manage your subscriptions Unsubscribe

Copyright ©2026 Digital Science Press, LLC